| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |